Bourke, Claire D <br/><br/>
Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis.  [electronic resource] 

 -  The Journal of infectious diseases  Jul 2013 
 - 159-69 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jis524  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Animals<br/>Anthelmintics--therapeutic use<br/>Child<br/>Child, Preschool<br/>Cytokines--blood<br/>Female<br/>Humans<br/>Immunity, Innate--immunology<br/>Interferon-gamma--blood<br/>Interleukin-10--blood<br/>Interleukin-12--blood<br/>Interleukin-13--blood<br/>Interleukin-17--blood<br/>Interleukin-2--blood<br/>Interleukin-23--blood<br/>Interleukin-4--blood<br/>Interleukin-5--blood<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Interleukins--blood<br/>Male<br/>Praziquantel--therapeutic use<br/>Schistosoma haematobium--immunology<br/>Schistosomiasis--drug therapy<br/>Schistosomiasis haematobia--drug therapy<br/>Th1 Cells--immunology<br/>Th17 Cells--immunology<br/>Th2 Cells--immunology<br/>Tumor Necrosis Factor-alpha--blood<br/>Interleukin-21